Thalidomide and venous thrombosis.
Escudier
B
B
Lassau
N
N
Leborgne
S
S
Angevin
E
E
Laplanche
A
A
D020533:Angiogenesis Inhibitors / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy*; D013792:Thalidomide / Q000009:adverse effects*; D020246:Venous Thrombosis / Q000139:chemically induced*
D020533:Angiogenesis Inhibitors; D000970:Antineoplastic Agents; D013792:Thalidomide